Company ProfilePremium

Shandong Ruifeng Chemical Co., Ltd.

Company Profile Analysis

Ticker: 300243.SZ山东瑞丰高分子材料股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Shandong Ruifeng Chemical Co., Ltd. - Company showcase

Year Founded & Workforce

1994

905 Employees

Shandong Ruifeng Chemical Co., Ltd. logo

Shandong Ruifeng Chemical Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Shandong Ruifeng Chemical Co., Ltd. Overview

Two similarly named listed companies should not be confused with it. 瑞丰新材 (300910.SZ), Xinxiang Richful Lube Additive, makes lubricant additives. 瑞丰转债 (123126) is this company's own convertible bond, which has now been redeemed.

Shandong Ruifeng is one of China's leading producers of PVC processing and impact-modifying additives. It has about 200,000 t/yr of combined capacity across ACR acrylic processing aids and impact modifiers, MBS impact modifiers and MC impact modifiers. The company describes itself as the leader in domestic ACR and MBS, supplying close to 3,000 domestic customers and exporting to more than 60 countries under the "LUSHAN" brand. Earnings are thin and cyclical: net margin was 1.1%–5.0% over FY2021–FY2025, because the business is exposed to acrylate, butadiene and styrene costs and to PVC demand tied to construction. Management is reshaping the company into a broader "new materials" platform:

  • higher-margin engineering-plastic additives and core-shell rubber (CSR) tougheners aimed at replacing imports;

  • a 60 kt/yr PBAT biodegradables line being retrofitted for PETG/PCTG specialty polyester;

  • early-stage black phosphorus anode material, SBR battery binder and dextran;

  • since September 2026, a proposed CNY 499M controlling acquisition of loss-making electronic-resin maker Anhui Mituo, which would take it into copper-clad laminate (CCL) materials.

H1 2026 profits rose sharply year on year, and the share price has nearly doubled in 2026.


Company's own description

In its FY2024 annual report summary, the company describes its core business as plastic additives in two lines.

General-purpose plastic (PVC) additives: The main products are ACR processing aids and impact modifiers, MBS impact modifiers and MC impact modifiers, with combined capacity of nearly 200,000 tonnes. Each product family has its own end uses:

  • ACR goes into PVC pipes, profiles, WPC and SPC flooring, wall panels, transparent sheet and foam board.

  • MBS goes into transparent PVC sheet (pharmaceutical and consumer packaging), pipes, magnetic-card materials and functional films.

  • MC goes into wire and cable, hoses, tapes, rubber sheet and PVC profile/pipe modification.

Engineering-plastic additives: The main products are PC/ABS toughening modifiers, ABS high-rubber powder and ASA rubber powder. The company states that domestic supply of these grades has historically been imported, mainly from Kaneka (Japan), Dow (US) and LG (Korea), and that its products have reached volume sales.

The same report says the company has 60,000 t/yr of PBAT biodegradable polymer capacity.

In a June 2025 institutional site-visit record, management organised the business into four segments: plastic-additive materials, polyester materials, new-energy materials and synthetic-biology materials. Tianfeng Securities (July 2026) describes the structure as "PVC additives + engineering-plastic additives + synthetic-biology materials + new materials". MarketScreener's summary of the filings describes three businesses: plastic additives; biodegradable materials (PBAT); and a "new product" business covering special polyester, synthetic biomaterials, battery binders and black phosphorus.

Independent characterisation

Ruifeng is best understood as a mid-cap commodity-to-specialty intermediate chemical producer. More than 90% of revenue still comes from a single mature product family, PVC additives. Revenue is almost entirely product sales: tonnage-based, priced off raw-material costs, and with no meaningful service, subscription or licensing income. S&P data show "other revenue" of only CNY 2–7M a year.

Value-chain position. Ruifeng buys monomers and polymers, including methyl acrylate, butyl acrylate, butadiene, styrene and HDPE, and polymerises them into core-shell or chlorinated polymer additives. Compounders and converters use these at 1–10 phr loadings in PVC and engineering-plastic processing. The additive is a small share of the customer's bill of materials but critical to performance, such as impact strength, melt processing and transparency. That gives Ruifeng moderate pricing power in normal markets. Tianfeng notes the company reprices flexibly in line with raw materials, but price competition intensifies in downturns: management cut prices in Q1 2025 to defend market share.

Customer types. PVC pipe, profile, flooring and sheet extruders (heavily tied to construction and real estate); packaging film and pharmaceutical blister-sheet producers; card makers; ABS/ASA and PC/ABS compounders serving automotive and electronics; and, in development, lithium-ion battery cell makers (SBR binder) and CCL laminators (CSR, and electronic resins through the Mituo deal).

End-market exposure. Construction and building materials are the largest exposure through PVC pipes, profiles and flooring. Packaging, consumer goods, automotive, electrical/electronics, agriculture and disposable packaging (PBAT mulch films and bags), and new energy and electronics (developing) make up the rest. Management has said it is deliberately shifting PVC-additive sales toward non-property uses such as sheet, cards, packaging film and pharmaceutical packaging to offset the property cycle (H1 2026 commentary).

Revenue model mix. About 100% product sales. Service, subscription and licensing revenue are not publicly disclosed and are assessed as immaterial.

Strategy

Stated strategy

Management has stated its themes consistently across the FY2024 annual report, the 2025 results briefings and the 2026 investor Q&A:

  1. Pursue "transformation and upgrading" (转型升级) while staying focused on the core business.

  2. Concentrate on the new-materials industry.

  3. Move plastic additives toward high-end, fine-chemical grades, replacing imports from Japanese, Korean, US and European incumbents.

  4. Cultivate new growth points in polyester, new-energy and synthetic-biology materials.

Since August 2026 the company has added an explicit ambition to enter the CCL and electronic-resin value chain.

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDetailTargets / status
Engineering-plastic additive expansion60 kt/yr new capacity: Phase 1 of 20 kt (including 5 kt CSR) under construction; Phase 2 of 40 kt (including 5 kt CSR)Phase 1 start-up end-2026; Phase 2 to start in 2027
Import-substitution gradesTransparent ABS toughener (in mass production); PMMA toughener, CSR, silicone-acrylic modifiers (small-batch or pilot)Batch production 2026–2027
PBAT line retrofit to PETG/PCTGLets the 60 kt/yr line co-produce specialty copolyestersFirst targeted for 2H2025
Black phosphorus industrialisationTonne-scale pilot built (Ruifeng Yueneng)Trial production; partnerships with downstream firms and research institutes
SBR battery binderMultiple grades; IATF 16949 certified; sampling with top cell makersCustomer qualification
DextranVeterinary iron-dextran precursorSmall-batch sales; expand capacity "as appropriate"
PVC-additive end-market rebalancingPush into sheet, card, packaging film and pharmaceutical packaging to reduce property-cycle exposureH1 2026 volume and margin up
Digital manufacturingShandong Provincial Smart Factory designationAchieved Jul 2025
Capital structureDownward revision of conversion price (Dec 2024), then forced conversion and redemption of the bond (Jun 2026)Leverage materially reduced
Electronic-chemicals entry (Anhui Mituo)CNY 499M for 68.065%Pending EGM; see Section 11
Dividend policyCash dividends maintained even in the weak FY2024 (CNY 0.05/share)FY2025 dividend approved May 2026

Medium-term guidance

MetricFY2026EFY2027EFY2028E
Revenue (CNY M, Tianfeng estimate)2,2042,6473,138
Revenue growth (%, Tianfeng estimate)11.9620.0618.58
Net income to shareholders (CNY M, Tianfeng estimate)126200316
EPS (CNY, Tianfeng estimate)0.450.721.13

The company has not published quantitative medium-term financial targets; no numeric revenue or margin guidance was identified. The only sell-side forecast found is from Tianfeng Securities (initiation, 13 Jul 2026):

These forecasts predate the Mituo deal.

Products & Services

PVC additives (LUSHAN brand)

ProductDescription and functionKey applicationsTarget customerStatus / capacity
ACR processing aidsAcrylic (PMMA-based) copolymers that speed PVC fusion, improve melt strength and surface finishPVC pipes, profiles, sheet, foam productsPVC extrudersCore; part of 100 kt/yr ACR capacity
ACR impact modifiersAcrylic core-shell impact modifiers that give weather-resistant toughnessWindow and door profiles, pipes, fittings, WPC/SPC flooring, wall panelsProfile and flooring makersCore. The company claims to be China's largest ACR producer.
Medium/ultra-high-MW acrylic processing aids (foam regulators)High-molecular-weight ACR for cell-structure control in foamed PVCPVC foam board, foam pipes, WPCFoam-board and WPC makersFlagship differentiated grade (cited by Morningstar)
MBS impact modifiersMethyl methacrylate-butadiene-styrene core-shell modifier; transparent impact modificationTransparent PVC sheet (pharmaceutical blisters, consumer packaging), pipes, magnetic and smart cards, functional filmsSheet and card makers60 kt/yr. Described as a domestic leader with over 20 years of MBS experience.
MC impact modifiersChlorinated-polyolefin type modifier (closely related to CPE)Wire and cable, hoses, tapes, rubber sheet, PVC profile/pipe modificationCable and rubber compounders40 kt/yr
CPE-135AChlorinated polyethylene impact modifierPVC profiles and pipesPVC processorsListed in third-party catalogues; may overlap with the MC line
Methyl tin mercaptideOrganotin heat stabiliserTransparent and rigid PVCPVC processorsListed on the company store / Knowde; scale not disclosed
PVC lubricants / lubricating processing aidsInternal and external lubricantsRigid PVCPVC processorsListed; scale not disclosed
Epoxidised soybean oilBio-based secondary plasticiser and co-stabiliserFlexible PVCPVC processorsListed; scale not disclosed

Pricing model: spot and contract tonnage pricing, adjusted to raw-material costs. FY2025 average realised price was about CNY 11,576/t (Tianfeng). List prices are not disclosed.

Engineering-plastic additives

ProductDescriptionApplicationsCompeting incumbents (per company)Status
PC/ABS toughening modifierCore-shell impact modifier for PC and PC/ABS alloysAutomotive, electronicsKaneka, Dow, LG ChemVolume sales
ABS high-rubber powderGrafted polybutadiene rubber powder blended with SAN to make ABSAutomotive, appliances, electrical, buildingKumho, BASF (high-end grades)Volume sales
ASA rubber powderAcrylate-rubber terpolymer blended with SAN to make weather-resistant ASAOutdoor and automotive exterior, buildingImportsVolume sales
Transparent ABS toughenerTransparent-grade core-shell modifierConsumer electronics, housingsImportsMass production and shipments began in 2026
PMMA toughenerImpact modifier for acrylic sheetLighting, displaysImportsSmall-batch sales
Silicone-acrylic impact modifierLow-temperature tougheningAutomotive, electronicsImportsPilot or scale-up done; batch production planned 2026–27
CSR (core-shell rubber) epoxy toughenerToughener for epoxy systemsCCLs including for AI servers, adhesives, compositesKaneka (benchmarked high-end grades)Small-batch from pilot line. 5 kt/yr in Phase 1 (end-2026) and 5 kt/yr in Phase 2.

Capacity: 10 kt/yr existing, running at full utilisation. A 60 kt/yr project is planned: Phase 1 of 20 kt/yr (including 5 kt CSR) targeted to start up by end-2026, and Phase 2 of 40 kt/yr (including 5 kt CSR) to start "at an appropriate time" in 2027. Average price in FY2025 was about CNY 16,093/t.

Polyester materials

ProductDescriptionApplicationsStatus
PBATBiodegradable aliphatic-aromatic copolyesterAgricultural mulch film, shopping bags, disposable packaging60 kt/yr line; batch sales achieved. The line did not run normally in FY2024 and was impaired by CNY 12.30M.
PBSBiodegradable polyesterPackagingPart of the polyester platform; scale not disclosed
PLA (resale/compounds)Polylactic acidCompostable productsListed by third-party profile (roic.ai)
PETG / PCTGGlycol-modified copolyestersCosmetics and personal-care packaging, appliances, sheet and film, medical devices, 3D printingPilot complete. The PBAT line is being retrofitted for co-production; management first targeted 2H2025 for normal running.

New-energy materials

ProductDescriptionStatus
Black phosphorus (Ruifeng Yueneng, controlled subsidiary)Layered phosphorus allotrope with high theoretical capacity and conductivity, targeted at fast-charge and solid-state anodes100 kg-scale unit ran normally in 2024. A tonne-scale pilot is built and in trial production, with application partnerships being pursued. No commercial revenue disclosed.
SBR lithium-ion battery binderStyrene-butadiene rubber binder for graphite anodes, building on MBS emulsion know-howSeveral grades launched; IATF 16949 certified; samples with multiple leading cell makers. Management said in May 2024 that no supply relationship had yet been established.

Synthetic-biology materials

ProductDescriptionStatus
Dextran (Ruifeng Bio subsidiary)Polysaccharide used to make iron dextran, an injectable veterinary iron supplementSmall-batch sales; capacity to expand depending on market development

Other chemicals

ProductNote
Epichlorohydrin (ECH)Listed by Simply Wall St and Investing.com. Management says ECH is a raw material for Anhui Mituo's epoxy resins, which is one stated synergy of the acquisition. Volume not disclosed.

Financial Narrative

Source: S&P Global Market Intelligence, normalised from CAS filings (via StockAnalysis.com, last updated Jul 2026). Key lines were cross-checked against the FY2024 annual report summary: revenue CNY 2,000.79M; net profit to shareholders CNY 22.08M; recurring (non-GAAP-equivalent "扣非") net profit CNY 18.42M; operating cash flow −CNY 23.20M; weighted ROE 1.92%. All values are in CNY millions unless labelled.

Income statement

Revenue CAGR FY2021–FY2025: about 1.5% a year (derived: (1969/1858)^(1/4) − 1).

Interim and quarterly data

Source: FY2024 annual report summary. The Q4 2024 loss reflects the PBAT impairment and year-end charges.

H1 2026 (company report, 27 Jul 2026):

  • Revenue CNY 1,097M (+9.04%); net profit CNY 58.94M (+348.43%); basic EPS CNY 0.23.

  • Gross margin 18.86%; net margin 5.35%.

  • Q2 2026: revenue CNY 575M (+8.07%) and net profit CNY 38.70M (+392.42%). Q1 2026 net profit was CNY 20.24M (+282.99%).

  • Operating cash flow per share was only about CNY 0.02, roughly CNY 6.23M in total.

  • On S&P TTM data to June 2026: revenue CNY 2,060M, EBITDA CNY 213.57M, net income CNY 76.13M, gross margin 17.12%.

Balance sheet

30 June 2026 (S&P): total debt fell to CNY 570.44M after the bond converted to equity. Long-term debt is now only CNY 19.60M; short-term debt is CNY 545.18M plus CNY 5.15M current portion of LTD. Net debt is CNY 288.07M, equity CNY 1,548M and book value per share CNY 5.54. Paid-in capital rose by about CNY 406M as bonds converted.

Cash flow

Note on buybacks: no buyback programme was identified in this research. S&P's FY2021 "issuance of common stock" of CNY 340M is the convertible bond proceeds as classified by S&P, and FY2023's CNY 123.6M includes the controller placement.

Ratios

Ratios are derived from the S&P data above unless marked as reported. ROE uses year-end equity except for the company-reported weighted ROE rows. ROIC is computed as EBIT × (1 − effective tax rate) / (total debt + equity).

Stockstar, citing historical annual data, gives ROIC of 3.36% for FY2025 and about 3% for FY2024, with a 10-year median of 6.74%. This is consistent with the computed series.

TTM to June 2026 (derived): net debt to EBITDA 1.35x; EBIT interest coverage 3.22x; debt to equity 0.37x.

Commentary

Revenue. Revenue has been flat at roughly CNY 1.8–2.0bn since FY2021. The 42.75% jump in FY2021 reflected raw-material pass-through as acrylate and butadiene prices spiked. FY2024's 12.66% rise came from volume, as the company traded price for share. The FY2025 decline of 1.59% came despite 7.6% higher PVC-additive volumes, meaning realised prices fell. The FY2021–25 CAGR of about 1.5% confirms a mature core business.

Margins. Gross margin compressed from 18.4% (FY2021) to 14.1% (FY2024) because:

  1. raw-material volatility outran price pass-through;

  2. the company cut prices deliberately to hold share (Q1 2025 management commentary);

  3. the idle PBAT asset added fixed cost.

The inflection came in H1 2026, when gross margin reached 18.86%. Methyl acrylate costs fell about 10% while butadiene and styrene rose 14% and 7% (Tianfeng, YTD to 3 Jul 2026), and management pushed through broad price increases. A richer engineering-additive mix also helped.

PBAT drag. The PBAT project explains most of the FY2024 collapse. Management quantified the hit at nearly CNY 64M: depreciation and bond-interest amortisation of CNY 39.88M plus CNY 12.30M of impairment and other items. D&A rose from CNY 57.8M to CNY 92.8M and interest expense nearly doubled to CNY 41.8M. Because the bond's effective-interest amortisation stopped after the June 2026 conversion and redemption, about CNY 20M+ a year of non-cash financing cost should fall away from 2H2026. This is a key mechanical earnings tailwind.

Cash flow. Cumulative free cash flow over FY2021–FY2024 was about −CNY 495M. It was funded by the CNY 340M convertible bond, the CNY 105M placement and rising bank debt. FY2025 was the first meaningfully positive FCF year (CNY 99.4M), as capex fell to CNY 33.7M and inventory was released.

Working capital. This is a structural weakness. Receivables days rose from about 89 to about 124 over five years, and the cash conversion cycle rose from about 85 to about 155 days. H1 2026 operating cash flow of only about CNY 6M, against CNY 59M net profit, shows the issue persisting. This matters now because up to CNY 350M of the Mituo price is to be financed with acquisition loans.

Balance sheet. Before conversion, leverage of 3.5–3.8x net debt to EBITDA was high for a cyclical business. The bond conversion transformed the balance sheet: equity rose to CNY 1.55bn and net debt fell to CNY 288M. That headroom is being redeployed into the Mituo acquisition, which pro forma would add up to CNY 350M of new debt plus Mituo's own net liabilities (CNY 434M of liabilities at 30 Jun 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment (Management Definition) Overview

Segment (management definition)ContentsStatus

Plastic-additive materials: PVC additives

ACR processing aids and impact modifiers (100 kt/yr); MBS impact modifiers (60 kt/yr); MC impact modifiers (40 kt/yr). Third-party profiles also list CPE-135A, methyl tin mercaptide, PVC lubricants, epoxidised soybean oil and ultra-high-molecular-weight processing aids.

Core; over 90% of revenue

Plastic-additive materials: engineering-plastic additives

PC/ABS toughening modifiers, ABS high-rubber powder, ASA rubber powder, transparent ABS toughener, PMMA toughener, silicone-acrylic impact modifiers, CSR (core-shell rubber) epoxy toughener

Fast-growing; 10 kt/yr running at full utilisation; 60 kt/yr expansion under way

Polyester materials

PBAT/PBS biodegradables (60 kt/yr line); PETG/PCTG specialty copolyester (pilot complete; retrofit of PBAT line)

Under-utilised; impaired in FY2024

New-energy materials

Black phosphorus anode material (subsidiary Ruifeng Yueneng 瑞丰玥能); SBR lithium-ion battery binder

Pilot and qualification stage

Synthetic-biology materials

Dextran, used for iron-dextran veterinary iron supplements (subsidiary Ruifeng Bio 瑞丰生物)

Small-batch sales

Proposed: electronic chemicals

Electronic-grade epoxy, low-dielectric resins (PPO, BMI, hydrocarbon), photo-initiators, via Anhui Mituo (68.065%)

Pending shareholder approval

Revenue by Segment and Revenue by Segment (%)

MetricFY2023FY2024FY2025

Total revenue (CNY Mn, reported)

1,7762,0011,969

PVC additives revenue (CNY Mn; FY2023 and FY2025 derived)

1,7321,8881,817

Engineering-plastic additives revenue (CNY Mn; FY2023 derived)

34107147

PVC additives share of total revenue (%)

97.594.492.3

Engineering-plastic additives share of total revenue (%)

1.95.37.5

PVC additives revenue growth YoY (%)

—9.0-3.8

Engineering-plastic additives revenue growth YoY (%)

—212.537.8

Engineering-plastic additives gross margin (%; FY2024 derived)

—23.625.8

PVC additives sales volume (kt; FY2024 derived)

—145.9157.0

Engineering-plastic additives production volume (kt; FY2024 derived)

—6.510.0

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (CNY Mn)

1,8581,8321,7762,0011,969

Revenue growth YoY (%)

42.75-1.45-3.0312.66-1.59

Cost of revenue (CNY Mn)

1,5171,5371,4681,7191,682

Gross profit (CNY Mn)

341.48294.44308.24282.03286.80

SG&A (CNY Mn)

182.22209.92187.34186.03204.23

R&D (CNY Mn, S&P normalised)

4.316.4314.609.018.57

Operating income / EBIT (CNY Mn)

148.3671.26105.6377.4776.49

D&A (CNY Mn)

40.6753.2857.8292.8495.15

EBITDA (CNY Mn)

189.04124.54163.45170.31171.63

Interest expense (CNY Mn)

20.7121.2322.5841.7844.00

Pre-tax income (CNY Mn)

106.5371.9889.9932.2733.29

Income tax (CNY Mn)

15.4910.844.7110.563.53

Net income to shareholders (CNY Mn)

92.8761.1485.2922.0830.33

Recurring net income ex non-recurring items (CNY Mn)

—47.0381.8718.42—

EPS basic (CNY)

0.400.260.360.100.13

EPS diluted (CNY)

0.390.260.360.100.13

Dividend per share declared for fiscal year (CNY, S&P)

0.1200.100.050.10

Gross margin (%)

18.3816.0817.3614.1014.57

Operating margin (%)

7.983.895.953.873.89

EBITDA margin (%)

10.176.809.208.518.72

Net margin (%)

5.003.344.801.101.54

Effective tax rate (%)

14.5415.065.2432.7010.60

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement

MetricQ1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024

Revenue (CNY Mn)

488.07492.22489.71530.78

Net income to shareholders (CNY Mn)

9.7813.0013.79-14.49

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (CNY Mn)

1,6881,9422,1742,2732,311

Cash and equivalents (CNY Mn)

233.33186.05305.81280.06358.67

Accounts receivable incl. notes (CNY Mn)

452.06509.27525.82614.54669.38

Inventory (CNY Mn)

118.58203.10217.16321.45272.01

PP&E (CNY Mn)

647.01811.45900.54861.23797.55

Construction in progress (CNY Mn)

221.96336.6551.4944.2240.00

Goodwill (CNY Mn)

00000

Other intangible assets (CNY Mn)

75.6999.4296.6293.8298.26

Short-term debt incl. current portion of LTD (CNY Mn)

185.98383.75363.42491.51546.20

Long-term debt incl. convertible bond (CNY Mn)

385.76374.56425.49441.62423.10

Total debt (CNY Mn)

571.74758.31789.43933.39969.30

Net debt (CNY Mn)

338.41572.26483.62653.34610.63

Shareholders' equity (CNY Mn)

894.04935.491,1411,1251,142

Working capital (CNY Mn)

474.61324.71505.82553.49599.61

Book value per share (CNY)

3.854.034.564.494.56

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (CNY Mn)

111.14-8.6296.20-23.20133.04

Capital expenditure (CNY Mn)

271.58176.31153.3069.3033.67

Free cash flow (CNY Mn)

-160.44-184.93-57.10-92.5099.37

Change in working capital (CNY Mn)

-43.87-147.13-67.71-196.04-33.20

Cash dividends paid (CNY Mn)

39.9937.118.5038.4930.88

Equity issued (CNY Mn)

340.000123.6000

Net debt issued/repaid (CNY Mn)

-75.95178.80167.73197.03181.00

Share buybacks (CNY Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE on year-end equity (%)

10.396.547.471.962.66

ROE weighted, company reported (%)

—6.708.631.92—

ROA on year-end assets (%)

5.503.153.920.971.31

ROIC computed (%)

8.653.585.192.533.24

Current ratio (x)

2.191.521.841.791.81

Debt to equity (x)

0.640.810.690.830.85

Net debt to EBITDA (x)

1.794.592.963.843.56

Interest coverage, EBIT / interest (x)

7.163.364.681.851.74

Asset turnover (x)

1.100.940.820.880.85

Days sales outstanding

89101108112124

Days inventory outstanding

2948546859

Days payables outstanding

3233352628

Cash conversion cycle (days)

85117127154155

Revenue by Region and Revenue by Region (%)

MetricFY2023FY2024FY2025

Total revenue (CNY Mn)

1,7762,0011,969

United States share of total revenue (%)

—0.49—

Valuation Snapshot

MetricValueDate / source

Last close

CNY 20.38

30 Sep 2026 (StockAnalysis)

Recent pre-rally price

CNY 10.69

Dec 2025 (Simply Wall St)

Approximate year-to-date change

About +90% (derived: 20.38 / 10.69)

—

52-week low / high

CNY 9.75 / 24.18

MarketScreener (Sep 2026)

3-year and 5-year low

CNY 5.12

MarketScreener

Free float

About 58.8%

MarketScreener

Valuation Multiples

MultipleRuifengNote

Market cap

About CNY 5,697M

Derived

Enterprise value

About CNY 5,985M

Derived

P/E (TTM EPS CNY 0.33)

About 62x

Derived

P/E FY2026E (Tianfeng EPS CNY 0.45)

About 45x

Derived

P/E FY2027E (Tianfeng EPS CNY 0.72)

About 28x

Derived

EV/EBITDA (TTM EBITDA CNY 213.6M)

About 28x

Derived

EV/Sales (TTM revenue CNY 2,060M)

About 2.9x

Derived

P/B (BVPS CNY 5.54)

About 3.7x

Derived

Peer reference

Tianfeng comparables (Chenghe, Jianbang, Shengquan) average 2027 P/E of 30.73x

Tianfeng, Jul 2026

Analyst Ratings & Targets

BrokerDateRatingTarget priceNote

Tianfeng Securities

13 Jul 2026

Buy (initiation)

CNY 21.98

Based on 30.73x 2027E P/E

Per-Share Data and Dividends & Capital Returns

MetricFY2021FY2022FY2023FY2024FY2025

DPS declared for fiscal year (CNY, S&P)

0.1200.100.050.10

Cash dividends paid in year (CNY Mn)

39.9937.118.5038.4930.88

Payout ratio of net income (%; derived from declared DPS × basic shares)

30.0027.850.076.8

Capital Markets

ItemDetail

International credit ratings (Moody's, S&P, Fitch)

None; unrated

Debt maturity profile, 30 Jun 2026

Short-term borrowings CNY 545.18M; current portion of long-term debt CNY 5.15M; long-term debt CNY 19.60M; leases about CNY 0.5M. About 97% of debt matures within one year (rolling bank facilities).

Pending new debt

Up to CNY 350M of M&A loans for Mituo

Analyst Conclusions

Guidance and expectations

Management gives no quantitative guidance. Qualitatively it expects:

  • seasonal recovery in PVC demand in Q3 (PVC prices rebounded from July 2026);

  • Phase 1 of the engineering-additive expansion (20 kt/yr including 5 kt CSR) by end-2026;

  • continued ramp-up of new grades through 2026–27;

  • gradual volume build at Mituo from 2H2026 into 2027, with no near-term profit expected from the target.

Tianfeng's forecasts, the only ones found, are revenue of CNY 2.20bn / 2.65bn / 3.14bn and net profit of CNY 126M / 200M / 316M for FY2026–FY2028. Annualised H1 2026 net profit of about CNY 118M makes the FY2026 figure plausible, before Mituo consolidation losses.

Bull case

  1. Operating leverage on recovery. Gross margin rose from 14.6% (FY2025) to 18.9% (H1 2026). Every percentage point of gross margin on about CNY 2.1bn of revenue is worth about CNY 21M of pre-tax profit, against a FY2025 net-profit base of only CNY 30M.

  2. Mix shift plus capacity. Engineering-plastic additives grow from 10 to 30 kt/yr effective capacity by 2027 at a roughly 39% price premium and a 25.8% gross margin. Substituting Kaneka-grade CSR and toughener imports in AI-server CCLs could lift group margin structurally.

  3. Cleaner balance sheet and cost relief. Bond conversion removed about CNY 400M of debt and about CNY 20M+ a year of interest amortisation. Net debt to EBITDA fell to 1.35x, creating capacity to fund growth.

Bear case

  1. Value-destructive M&A. CNY 499M (about 9% of current market cap) for a target with CNY 41M of revenue and a CNY 62.5M loss, at 5.5x book, financed with up to CNY 350M of loans. The 2027 commitment is a loss, and the reported compensation cap covers under 9% of the commitment. Consolidating Mituo could erase a large part of 2027 earnings growth.

  2. History of failed diversification. The PBAT plant (CNY 263M of bond proceeds) was idle and impaired, the PETG retrofit timing has slipped, SBR has no supply contracts, and black phosphorus is still in trial production.

  3. Cyclical, cash-poor core. A cash conversion cycle of about 155 days, H1 2026 operating cash flow of about CNY 6M, and a PVC market described as in post-peak structural adjustment. A raw-material spike (butadiene +14% YTD) or property weakness could quickly reverse margin gains. A valuation of about 62x trailing P/E leaves no room for error.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableTiming
EGM vote on the Mituo acquisition and loan financingOct–Nov 2026
Q3 2026 report (margins, operating cash flow, receivables)By 31 Oct 2026
Start-up of Phase 1 engineering-additive capacity (20 kt including 5 kt CSR)End-2026
FY2026 annual report; any PBAT/PETG impairment; Mituo consolidation effectApr 2027
PETG/PCTG commercial production statusOngoing
SBR binder supply contract or black phosphorus commercial ordersOngoing
Raw-material spreads (MMA/MA, butadiene, styrene) and PVC price trendMonthly
Short-term debt refinancing and new M&A borrowingOngoing
Further broker initiations and FY2026 dividend2026–27

Analyst verdict

Shandong Ruifeng Chemical is a credible domestic leader in a mature, low-margin niche that is trying to buy and build its way into higher-value materials. The 2026 recovery is real. H1 net profit more than quadrupled, gross margin returned to about 19%, and the June 2026 forced conversion of its convertible bond cut net debt to under CNY 300M, removing the main mechanical drag that crushed FY2024 earnings. The most convincing growth engine is organic: the engineering-plastic additives business. It has grown at 38–42% a year, earns about 26% gross margin, is capacity-constrained at 10 kt/yr, and has a funded six-fold expansion whose first phase lands at end-2026. Core-shell polymer know-how built over 20 years in MBS is a genuine, transferable capability, and CSR tougheners for AI-server laminates give it a credible import-substitution story.

The investment case is now complicated by capital allocation. The CNY 499M Mituo acquisition was struck at about 5.5x book for a company losing more than its revenue and dependent on a handful of customers. Its debt funding re-levers a balance sheet that was only just repaired, and the weak protection in the earn-out recalls the PBAT episode, where CNY 263M of capital produced an idle, impaired plant. Cash conversion remains the chronic weakness: receivables keep lengthening, and H1 2026 operating cash flow was negligible against reported profit.

At about 62x trailing and about 45x FY2026E earnings (on Tianfeng's estimates), after a near-doubling of the share price, the market is already paying for successful execution of both the organic expansion and the Mituo turnaround. Our assessment is constructive on operations but cautious on valuation and governance: fundamentally attractive only if Q3–Q4 2026 confirm margins above 17% with positive operating cash flow, and if the Mituo terms are approved with tighter protection or a smaller cash commitment. Investors should treat the EGM vote and the Q3 cash-flow print as decisive near-term tests.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / notesAge (source)

Zhou Shibin (周仕斌)

Chairman; controlling shareholder and actual controller

Director since 2009 conversion; MarketScreener lists chairman since 1 Sep 2009. Signs the annual report as legal representative.

61 (Investing.com); 64 (MarketScreener, later)

Liu Chunxin (刘春信)

General Manager (CEO) and Director

GM since 2016 (Investing.com); MarketScreener's CEO entry starts 6 Jul 2017

47 to 50

Xu Yueling (许曰玲)

CFO (Head of Finance)

MarketScreener: since 1 Jan 2010

54

Zhao Ziyang (赵子阳)

Board Secretary

IR lead in 2025–26 records

—

Song Zhigang (宋志刚)

Deputy GM and Director

Since 2016 (Investing.com)

56

Tang Chuanxun (唐传训)

Director

Since 2009

49

Wang Jian (王健)

Director; concert party of the controller

Since 2021 (Investing.com)

37

Shao Zeheng (邵泽恒)

Director

Investing.com

41

Xu Suxian (许肃贤)

Independent Director

Attended May 2025 results briefing

—

Wang Xiaodong

Independent Director (per Investing.com; may be legacy)

—56

Dong Hua

Independent Director (per Investing.com; may be legacy)

—46

Zheng Kai

Independent Director (per Investing.com; may be legacy)

—71

Xu Yingjie (徐颖杰)

Head of accounting function

Co-signs FY2024 financial statements

—

Zhu Xihai (朱西海)

Securities Affairs Representative

IR record, Jun 2025

—

“—” = not publicly disclosed.

Major Shareholders

HolderShares (M)% of floatChange in H1 2026Type

Zhou Shibin (controller)

16.85 tradable

7.53

Unchanged

Individual (total holdings including restricted shares are higher)

Sang Peizhou (桑培洲)

9.3984.20−22.55%

Individual (historic #2 holder)

Chen Qiang (陈强)

3.1991.43

New

Individual

Wu Jianning (伍建宁)

3.101.39−0.96%

Individual

Wei Guiying (魏贵英)

2.7841.24+16.99%

Individual

Cai Zhixing (蔡志兴)

2.7541.23+0.71%

Individual

Chen Wenjian (陈文健)

2.6581.19

Unchanged

Individual

Wang Gongjun (王功军)

2.6461.18−17.38%

Individual

Zhou Xiaoyuan (周晓渊)

1.6690.75

New

Individual

Wang Hongtao (王洪涛)

1.380.62

Unchanged

Individual

Competitive Landscape

Competitors by Segment

SegmentCompetitorCountryRelevant productsRelative positioning vs Ruifeng

PVC additives (ACR/MBS)

Kaneka Corporation

Japan

Kane Ace MBS/ACR, MX core-shell modifiers

Global technology leader and premium brand; much larger and diversified

PVC additives

Dow Inc.

US

Paraloid acrylic and MBS modifiers

Global leader; premium grades

PVC additives

Arkema

France

Durastrength, Plastistrength, Clearstrength

Global premium; strong in Europe and the Americas

PVC additives

Mitsubishi Chemical Group

Japan

Metablen modifiers

Premium Asian competitor

PVC additives / ABS powder

LG Chem

Korea

MBS, ABS high-rubber powder

Strong in Asia; integrated with ABS

PVC additives (domestic)

Shandong Rike Chemical (日科化学, 300214.SZ)

China

ACR, CPE, rubber-plastic modifiers

—

PVC additives (CPE/MC, domestic)

Weifang Yaxing Chemical (亚星化学, 600319.SH)

China

CPE

CPE specialist

Engineering-plastic additives

Kumho Petrochemical

Korea

ABS high-rubber powder

Incumbent in high-end ABS powder

Engineering-plastic additives

BASF

Germany

ABS/ASA rubber powders and modifiers

Incumbent in high-end grades

Polymer additives (Tianfeng comparables)

Chenghe Technology (呈和科技), Jianbang (键邦股份), Shengquan Group (圣泉集团)

China

Nucleating agents, PVC stabilisers, phenolic/epoxy resins

Valuation comparables; Shengquan is also an electronic-resin competitor

PBAT

Kingfa Sci & Tech; Xinjiang Blue Ridge Tunhe; others

China

PBAT

Industry overcapacity; Ruifeng is subscale

Electronic resins (Mituo)

Tongyu New Materials (同宇新材, 301630.SZ); Shengquan; Hongchang Electronic; Kolon; Nan Ya

China / Taiwan / Korea

CCL epoxy, PPO, BMI, hydrocarbon resins

Mituo is a small entrant (CNY 41M revenue in 2025)

SBR binder

Zeon; JSR; domestic binder makers

Japan / China

Anode SBR

Ruifeng is pre-commercial

Competitor Detail

MetricRuifeng FY2025

Revenue

CNY 1,969M

Revenue growth

−1.59%

Gross margin

14.57%

Operating margin

3.89%

R&D intensity

0.44% (S&P basis; CAS figure likely higher)

Company Snapshot

$273.9M

Revenue

905

Employees

1994

Founded

Shandong, China

Headquarters

SWOT Analysis

Strengths

  • Scale leadership in the core business: 200 kt/yr of ACR (100), MBS (60) and MC (40) capacity; identified by Tianfeng as the ACR and MBS leader.
  • Volume momentum: PVC-additive sales rose 7.6% to 157 kt in FY2025, and H1 2026 volume and gross margin both improved.
  • High-growth adjacent business: engineering-plastic additives grew 212% (FY2024), 37.75% (FY2025) and 42.51% (H1 2026), with a 25.79% gross margin against a 14.57% group average.
  • Deleveraged balance sheet: bond conversion lifted equity to CNY 1.55bn and cut net debt to CNY 288M (30 Jun 2026, from CNY 611M at FY2025).
  • Diversified customer base: close to 3,000 domestic customers and exports to more than 60 countries; US only 0.49% of FY2024 revenue.
  • Earnings recovery: H1 2026 net profit +348% to CNY 58.9M; gross margin 18.86%.
  • Controller alignment: the Chairman injected CNY 105M of equity at CNY 7.02/share (Dec 2023).

Weaknesses

  • Thin profitability: net margin of 1.10% (FY2024) and 1.54% (FY2025); computed ROIC of 2.5–3.2% in FY2024–25.
  • Poor cash conversion: cash conversion cycle of about 155 days in FY2025 (85 in FY2021); H1 2026 operating cash flow about CNY 6M against CNY 59M net profit.
  • Capital-allocation track record: the CNY 263M PBAT plant was idle in FY2024, with CNY 12.3M impairment and about CNY 64M total earnings hit.
  • Revenue concentration: more than 90% of revenue from PVC additives (FY2025 derived 92%).
  • Low reported R&D intensity: about 0.4% of revenue on S&P data, against multinational peers.
  • Heavy short-term borrowing: CNY 545M of short-term debt at 30 Jun 2026 against CNY 282M of cash.
  • Cumulative negative FCF: about −CNY 495M over FY2021–FY2024.

Opportunities

  • Engineering-additive capacity: 6x expansion (10 to 60 kt/yr); Phase 1 of 20 kt by end-2026 at about 39% higher average prices.
  • CSR import substitution: a global epoxy-toughener market of about USD 240M by 2029 (QYResearch), with Kaneka-benchmarked grades in small-batch sales and use in AI-server CCLs.
  • Electronic resins via Mituo: exposure to high-frequency/high-speed CCL resin demand from AI and data centres; cross-selling with CSR.
  • PETG/PCTG: reuse of the 60 kt/yr PBAT asset for specialty copolyester (cosmetics packaging, medical, 3D printing).
  • Black phosphorus and SBR binder: optionality on next-generation anodes and binders (tonne-scale pilot; IATF 16949).
  • Financing-cost relief: about CNY 20M+ a year of bond interest amortisation ends after the June 2026 redemption.
  • Southeast Asia: a reported Vietnam unit could serve regional PVC and flooring growth.

Threats

  • Raw-material volatility: butadiene +14% and styrene +7% YoY in 2026 YTD; FY2024 margin collapse from cost swings.
  • Property downturn: PVC demand tied to construction; PVC prices fell in Q2 2026.
  • Acquisition risk: Mituo lost CNY 62.5M in 2025, is valued at 5.5x book, has top-five customer concentration above 90%, and has a 2027 commitment that is itself a loss (−CNY 8M).
  • Re-leveraging: up to CNY 350M of M&A loans on top of CNY 545M short-term debt, while H1 2026 operating cash flow was only about CNY 6M.
  • Further impairment of the PBAT/PETG line if the retrofit underperforms, a risk the company flagged itself in its FY2024 report.
  • Competition from global incumbents (Kaneka, Dow, Arkema, LG Chem) with superior R&D, plus domestic price competition.
  • Share-price volatility: retail-dominated register (about 55%); YTD +78% at one point; −7% single-day moves.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
2 Apr 2025Q1 2025 bond conversion notice: zero conversions; 3,398,672 bonds (CNY 339.87M) outstanding; conversion price CNY 11.69The bond overhang was still fully outstanding
21 Apr 20253rd meeting of the 6th Board approves FY2024 accounts; SCPA issues a standard unqualified opinionClean audit after the auditor change
22 Apr 2025FY2024 annual report: revenue CNY 2,000.79M (+12.66%); net profit CNY 22.08M (−74.12%); PBAT impairment CNY 12.30MEarnings trough; risk warning on further PBAT impairment
Apr 2025Q1 2025 results: profit down on deliberate price cuts to protect market share and higher marketing spendShows the price-for-share trade-off
9 May 2025FY2024 online results briefing (Chairman, CFO, Board Secretary, independent director). US sales only 0.49% of revenue.Tariff exposure limited
15 May 2025Second results Q&A on black phosphorus timingInvestor focus on new energy
4–5 Jun 2025Site visit by Founder Securities, Caitong Fund, Zheshang Securities, Nuoan Fund, Dongcai Fund and Guojun Asset Management; four-segment strategy outlinedRising institutional interest
21 Jul 2025Designated a Shandong Provincial Smart FactoryOperational credential
13 Aug 2025Pays nearly CNY 7M of back taxes and surchargesMinor tax-compliance item
25 Aug 2025H1 2025 report releasedWeak base for 2026 comparisons
24 Oct 2025Q3 2025 report released (9M revenue about CNY 2.0bn TTM; trailing earnings CNY 9.9M per Simply Wall St)Profit still depressed
Dec 2025Shares trade around CNY 10.7; market cap about CNY 2.6–2.7bnPre-rerating baseline
Q1 2026PVC prices spike on export-rebate rush and Middle East-driven crude and ethylene costsInput-cost and pricing tailwind
14 Apr 2026FY2025 annual report: revenue CNY 1,969M (−1.59%); net profit CNY 30.33M (+37.4%); FCF positive at CNY 99MRecovery begins
15 Apr 2026FY2025 Board work report published (8 meetings in 2025; SBR grades launched and sampled)Governance disclosure
Apr 2026Q1 2026: net profit CNY 20.24M (+282.99%)Earnings inflection confirmed
6 May 2026Investor Q&A: engineering-plastic additives at full capacity; new grades to batch production 2026–27Capacity bottleneck explains the expansion
11 May 2026Shareholders approve the FY2025 cash dividendPayout continuity
May 2026Share price triggers the bond's conditional redemption; mass conversionDeleveraging
21 May 2026Controller stake diluted to 24.9958%; total shares 270.84MControl dilution
27 May / 1 Jun 2026Bond stops trading, then is redeemed and delistedRemoves about CNY 20M+ a year of interest amortisation and the convertible overhang
13 Jul 2026Tianfeng Securities initiates at Buy, target price CNY 21.98First visible sell-side coverage
27 Jul 2026H1 2026: revenue CNY 1,097M (+9.04%); net profit CNY 58.94M (+348.43%); gross margin 18.86%Strongest half-year in several years
28 Jul 2026Top-10 float holders change: new individual holders; Goldman Sachs International exits; Sang Peizhou trims 22.55%Retail-dominated register
14 Aug 2026Board approves the Mituo framework; shares +16.09%Strategic pivot to electronic resins
17–18 Aug 2026Framework announced (CNY 400–500M for at least 51%); shares close up more than 15% after repeated limit-up touchesMomentum-driven rerating
16 Sep 2026Definitive Mituo agreements: CNY 499M for 68.065%; 549.91% valuation uplift; up to CNY 350M of M&A loansLarge, levered bet on a loss-making target
17 Sep 2026Media scrutiny (Lanjing, Jiemian) of valuation, leverage, the negative 2027 commitment and the founder lock-in change. The company says the valuation is reasonable and losses reflect start-up stage.Reputational and governance overhang
30 Sep 2026Shares close at CNY 20.38 (−7.07% on the day)Volatility after the deal
Pending (Oct 2026)EGM vote on Mituo; Q3 2026 report due by 31 Oct 2026Near-term catalysts

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue rose from CNY 1,858 Mn in FY2021 to CNY 1,969 Mn in FY2025.
Shandong Ruifeng Chemical Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (CNY Mn)FY2021FY2022FY2023FY2024FY2025
Revenue1,8581,8321,7762,0011,969
Cost of revenue1,5171,5371,4681,7191,682
Gross profit341.5294.4308.2282286.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. CNINFO: FY2024 Annual Report and Summary (2025-011), FY2024 Financial Report (audit report 上会师报字(2025)第4754号), CITIC Securities FY2024 proceeds-use verification, Q1 2025 bond conversion notice (2025-008), IR records of 9 May 2025, 15 May 2025 and 6 Jun 2025, FY2025 Board work report (Apr 2026), bond redemption notice (21 May 2026), controller dilution notice (2026-036)
  2. S&P Global Market Intelligence via StockAnalysis.com: income statement, balance sheet and cash flow, FY2021–FY2025 and TTM to Jun 2026
  3. Tianfeng Securities initiation, 13 Jul 2026 (via Gelonghui)
  4. Cailian Press / Eastmoney (27 Jul 2026; 16 Sep 2026): Jiemian (27 Jul 2026 · Sep 2026) · Stockstar (27–29 Jul 2026); 10jqka (6 May 2026; 28 Jul 2026)
  5. Shanghai Securities News / 21st Century Business Herald (18 Aug 2026): Gelonghui (17 Aug 2026; 14 Dec 2022) · Lanjing News / Sina (17 Sep 2026) · Ruicaijing (17 Sep 2026)
  6. Daily Economic News (9–10 Jan 2017); uSmart / Gelonghui (Nov 2019: Jan 2020) · Sohu company profile
  7. Morningstar, MarketScreener, Simply Wall St, Investing.com, roic.ai, Knowde (company profile pages)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.